Weave Bio
Weave automates and accelerates regulatory submission preparation so biopharma teams can produce compliant dossiers faster. The Weave Platform is a cloud-native, AI-powered SaaS that extracts and structures source data, uses AI templates to auto-draft submissions (AutoIND, AutoCT), and validates content against global standards such as FDA eCTD with two-click traceability. It targets biotechs, pharmaceutical companies, CROs, and regulatory consultants and is built to integrate into life-sciences documentation and review workflows. The platform reduces manual regulatory work, improves consistency and compliance, and supports preclinical through approval-stage submissions.
Weave Bio
Weave automates and accelerates regulatory submission preparation so biopharma teams can produce compliant dossiers faster. The Weave Platform is a cloud-native, AI-powered SaaS that extracts and structures source data, uses AI templates to auto-draft submissions (AutoIND, AutoCT), and validates content against global standards such as FDA eCTD with two-click traceability. It targets biotechs, pharmaceutical companies, CROs, and regulatory consultants and is built to integrate into life-sciences documentation and review workflows. The platform reduces manual regulatory work, improves consistency and compliance, and supports preclinical through approval-stage submissions.
TL;DR
What they do: AI-native regulatory platform that automates preparation, authoring, review, and lifecycle management of regulatory dossiers for biopharma
Founded: 2023
Target customers: Biotech, pharmaceutical companies, CROs, and regulatory consultants
Reported funding: Approximately $43M total (multiple rounds including $10M and a reported $20M Series A)
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |
Company Overview
Problem Domain
Regulatory submission preparation and lifecycle management for life sciences organizations.
Founded
2023
Industry
Biotechnology
Tech Stack
Funding Track Record
10,000,000
Company press release announcing $10 million in funding
20,000,000
Company newsletter states $20M Series A to scale the platform
Investor Signal
“Innovation Endeavors; Magnetic Ventures; U.S. Venture Partners; Serrado Capital (listed as investors in company profiles and Crunchbase)”